FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988522912> ?p ?o ?g. }

• W1988522912 endingPage "27" @default.
• W1988522912 startingPage "18" @default.
• W1988522912 abstract "As part of the cross-national collaborative panic study, a double-blind comparison of alprazolam, imipramine and placebo was performed in Scandinavian outpatients with panic disorder according to DSM-III; 41 patients were randomly allocated to each drug. Doses were increased for 3 weeks to an average of about 6 mg alprazolam, 150 mg imipramine and a corresponding number of placebo capsules, which were then given for 5 weeks. No more than supportive psychotherapy was given. Key symptoms were rated weekly. The drugs were tapered for 4 or 8 weeks and the patients were followed up for 6 months. Compliance at 3 weeks was 95% for alprazolam, 83% for imipramine and 88% for placebo; at 8 weeks 95% for alprazolam, 73% for imipramine and 46% for placebo. At 3 weeks plasma determination showed that the proportion taking diazepam outside the protocol was 0% for alprazolam, 19% for imipramine and 31% for placebo; at 8 weeks the corresponding proportions were 3%, 11% and 16%. Intention-to-treat analysis showed that freedom from panic attacks was obtained for 68% with alprazolam, 61% with imipramine and 34% with placebo. Alprazolam was more effective than imipramine and placebo on anticipatory anxiety and phobic symptoms. Globally rated by physicians and patients, about 60% had complete remission with alprazolam and imipramine and 30% on placebo. At least partial remission was obtained in about 85% with alprazolam, 70% with imipramine and 40% with placebo. Alprazolam had a more rapid onset of action than imipramine on all symptoms. Side effects were generally mild, with a preponderance of drowsiness for alprazolam and anticholinergic effects for imipramine. Tapering was uneventful without significant discontinuation phenomena. During taper and follow-up, several patients in remission relapsed, leaving approximately 30% patients in complete remission in all groups. To obtain more stable improvement, either long-term drug treatment or combinations of drug treatment and psychotherapy should be evaluated." @default.
• W1988522912 created "2016-06-24" @default.
• W1988522912 creator A5000891143 @default.
• W1988522912 creator A5007343136 @default.
• W1988522912 creator A5007704902 @default.
• W1988522912 creator A5009885280 @default.
• W1988522912 creator A5030129449 @default.
• W1988522912 creator A5049015216 @default.
• W1988522912 creator A5055941006 @default.
• W1988522912 creator A5071289789 @default.
• W1988522912 creator A5076078915 @default.
• W1988522912 creator A5083468492 @default.
• W1988522912 creator A5084996693 @default.
• W1988522912 date "1991-07-01" @default.
• W1988522912 modified "2023-09-26" @default.
• W1988522912 title "Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study" @default.
• W1988522912 cites W1864769269 @default.
• W1988522912 cites W1984477821 @default.
• W1988522912 cites W2037061841 @default.
• W1988522912 cites W2049165791 @default.
• W1988522912 cites W2054989730 @default.
• W1988522912 cites W2068629053 @default.
• W1988522912 cites W2069644518 @default.
• W1988522912 cites W2071200229 @default.
• W1988522912 cites W2093837438 @default.
• W1988522912 cites W2114613490 @default.
• W1988522912 cites W2160070901 @default.
• W1988522912 cites W2176521126 @default.
• W1988522912 doi "https://doi.org/10.1111/j.1600-0447.1991.tb03097.x" @default.
• W1988522912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1862730" @default.
• W1988522912 hasPublicationYear "1991" @default.
• W1988522912 type Work @default.
• W1988522912 sameAs 1988522912 @default.
• W1988522912 citedByCount "73" @default.
• W1988522912 countsByYear W19885229122012 @default.
• W1988522912 countsByYear W19885229122013 @default.
• W1988522912 countsByYear W19885229122014 @default.
• W1988522912 countsByYear W19885229122015 @default.
• W1988522912 countsByYear W19885229122016 @default.
• W1988522912 countsByYear W19885229122018 @default.
• W1988522912 countsByYear W19885229122019 @default.
• W1988522912 countsByYear W19885229122022 @default.
• W1988522912 crossrefType "journal-article" @default.
• W1988522912 hasAuthorship W1988522912A5000891143 @default.
• W1988522912 hasAuthorship W1988522912A5007343136 @default.
• W1988522912 hasAuthorship W1988522912A5007704902 @default.
• W1988522912 hasAuthorship W1988522912A5009885280 @default.
• W1988522912 hasAuthorship W1988522912A5030129449 @default.
• W1988522912 hasAuthorship W1988522912A5049015216 @default.
• W1988522912 hasAuthorship W1988522912A5055941006 @default.
• W1988522912 hasAuthorship W1988522912A5071289789 @default.
• W1988522912 hasAuthorship W1988522912A5076078915 @default.
• W1988522912 hasAuthorship W1988522912A5083468492 @default.
• W1988522912 hasAuthorship W1988522912A5084996693 @default.
• W1988522912 hasConcept C118552586 @default.
• W1988522912 hasConcept C126322002 @default.
• W1988522912 hasConcept C142724271 @default.
• W1988522912 hasConcept C15744967 @default.
• W1988522912 hasConcept C204787440 @default.
• W1988522912 hasConcept C27081682 @default.
• W1988522912 hasConcept C2777196872 @default.
• W1988522912 hasConcept C2777529043 @default.
• W1988522912 hasConcept C2779145073 @default.
• W1988522912 hasConcept C2780712732 @default.
• W1988522912 hasConcept C42219234 @default.
• W1988522912 hasConcept C558461103 @default.
• W1988522912 hasConcept C71924100 @default.
• W1988522912 hasConceptScore W1988522912C118552586 @default.
• W1988522912 hasConceptScore W1988522912C126322002 @default.
• W1988522912 hasConceptScore W1988522912C142724271 @default.
• W1988522912 hasConceptScore W1988522912C15744967 @default.
• W1988522912 hasConceptScore W1988522912C204787440 @default.
• W1988522912 hasConceptScore W1988522912C27081682 @default.
• W1988522912 hasConceptScore W1988522912C2777196872 @default.
• W1988522912 hasConceptScore W1988522912C2777529043 @default.
• W1988522912 hasConceptScore W1988522912C2779145073 @default.
• W1988522912 hasConceptScore W1988522912C2780712732 @default.
• W1988522912 hasConceptScore W1988522912C42219234 @default.
• W1988522912 hasConceptScore W1988522912C558461103 @default.
• W1988522912 hasConceptScore W1988522912C71924100 @default.
• W1988522912 hasIssue "S365" @default.
• W1988522912 hasLocation W19885229121 @default.
• W1988522912 hasLocation W19885229122 @default.
• W1988522912 hasOpenAccess W1988522912 @default.
• W1988522912 hasPrimaryLocation W19885229121 @default.
• W1988522912 hasRelatedWork W1988522912 @default.
• W1988522912 hasRelatedWork W1994492291 @default.
• W1988522912 hasRelatedWork W2026437336 @default.
• W1988522912 hasRelatedWork W2091373414 @default.
• W1988522912 hasRelatedWork W2113117179 @default.
• W1988522912 hasRelatedWork W2130148956 @default.
• W1988522912 hasRelatedWork W2401242778 @default.
• W1988522912 hasRelatedWork W2401537224 @default.
• W1988522912 hasRelatedWork W2781790481 @default.
• W1988522912 hasRelatedWork W375123512 @default.
• W1988522912 hasVolume "83" @default.
• W1988522912 isParatext "false" @default.
• W1988522912 isRetracted "false" @default.

• next